IP Library Granted Patent US 12661327
Granted Patent B2
US 12661327 · App. 17/621,582 · Granted Jun 23, 2026

Aqueous patch

Inventor: Masahiro Inazuki (Kagawa, JP)
Assignee: TEIKOKU SEIYAKU CO., LTD.
A61K9/7023A61K9/0014A61K9/7046A61K9/7053A61K9/7061A61K31/045A61K31/167A61K31/192A61K45/06A61K47/02A61K47/10A61K47/44A61P23/02A61P25/02A61P29/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12661327
App. No.
17/621,582
Granted
Jun 23, 2026
Kind
B2
Abstract

The purpose of the present invention is to provide an aqueous patch in which basic physical properties as an aqueous patch are less likely to deteriorate and crystals of 1-menthol are less likely to precipitate. The aqueous patch includes, in a pasty preparation, 1-menthol: 0.5% by mass or more and 10% by mass or less, an oil component: 0.2% by mass or more and 19% by mass or less; and silica: 0.1% by mass or more and 5.5% by mass or less.

Claims (18)

1 . An aqueous patch comprising, in a pasty preparation,

1-menthol: 0.5% by mass or more and 10% by mass or less,

an oil component: 0.2% by mass or more and 19% by mass or less;

silica: 0.1% by mass or more and 5.5% by mass or less;

a drug;

a water-soluble polymer material; and

water,

wherein the drug comprises at least one selected from the group consisting of lidocaine and a pharmaceutically acceptable salt thereof,

wherein the oil component comprises castor oil,

wherein the ratio of total mass of the drug and the 1-menthol to mass of the oil component is 0.3 or more and 12 or less,

wherein the pasty preparation does not comprise loxoprofen or a pharmaceutically acceptable salt thereof, wherein the pasty preparation does not comprise methyl salicylate, and

wherein the pasty preparation does not comprise polybutene.

2 . The aqueous patch according to claim 1 , comprising, in the pasty preparation,

the drug: 0.5% by mass or more and 10% by mass or less.

3 . The aqueous patch according to claim 2 , wherein the ratio of total mass of the drug and the 1-menthol to mass of the oil component is 0.63 or more and 12 or less.

4 . The aqueous patch according to claim 1 , wherein the ratio of mass of the silica to mass of the oil component is 0.06 or more.

5 . The aqueous patch according to claim 1 , wherein the ratio of mass of the water-soluble polymer material to mass of the oil component is 0.65 or more.

6 . The aqueous patch according to claim 1 , wherein the silica is a powder having a specific surface area of 30 m 2 /g or more and 420 m 2 /g or less as measured by a specific surface area measurement method specified in JIS Z 8830.